Trade Mark Journal No.2026/026 26 June 2026

UK00004400526 10 June 2026 (5)

ARVEXA

Class 5: Pharmaceutical preparations for the treatment of Attention Deficit Hyperactivity Disorder (ADHD); none of the aforesaid being cannabis-based medicinal products.

Ridge Pharma Limited

Representative: Reddie & Grose LLP